HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nearly 9% FY 2019 Increase For FDA In Shutdown-Averting Appropriations Bill

Executive Summary

Consolidated Appropriations Act gives FDA $5.58bn overall, 8.7% more than allocated in FY 2018. FDA received $268.8m in additional budget authority and $178.3m in additional user fee funds. FY 2019 funding would have lapsed Feb. 16 and another government shutdown would have started if President Trump didn't sign the bill on Feb. 15.

Advertisement

Related Content

Generic Industry Once Again Must Get To Know New US FDA Office Director
Rare Diseases: US FDA Gives More Guidance On Premarket Safety Evaluation, Historical Controls
Shutdown Deal Avoids Further US FDA Service Cuts, But Damage May Linger
US FDA May Ask Congress For More Resources After Withdrawing Generic Label Reg
How One Rogue Scientist Could Sink Global Gene Therapy Progress
Project Renewal: US FDA's Plan To Update Generic Cancer Drug Labels Depends On NDA Holders
Opioid Prescribing Guidelines Will Be More Template Than Commandment
Office Of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions
House Appropriators Warn US FDA: Stop Working On Electronic Labeling Rule
FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan

Topics

Advertisement
UsernamePublicRestriction

Register

RS148547

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel